Newbridge Financial Services Group, Inc. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,0000.0%1,2690.0%0.00%
+100.0%
Q1 2022$3,000
-50.0%
1,269
-16.0%
0.00%
-66.7%
Q4 2021$6,0000.0%1,5100.0%0.00%
-25.0%
Q3 2021$6,000
+200.0%
1,510
+194.3%
0.00%
+300.0%
Q2 2021$2,000
-60.0%
5130.0%0.00%
-75.0%
Q1 2021$5,000
+25.0%
513
+20.1%
0.00%
+33.3%
Q4 2020$4,000
+100.0%
4270.0%0.00%
+50.0%
Q3 2020$2,0004270.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 233,730$369,2930.45%
COOPERMAN LEON G 812,508$1,283,8440.08%
CATALYST FINANCIAL PARTNERS LLC 14,475$22,8720.01%
Legend Financial Advisors, Inc. 1,000$1,5800.00%
GEODE CAPITAL MANAGEMENT, LLC 184,870$2920.00%
STATE STREET CORP 133,258$210,5480.00%
MORGAN STANLEY 55,201$87,2230.00%
BlackRock Inc. 69,937$110,5080.00%
Bank of New York Mellon Corp 36,062$56,9820.00%
Citadel Advisors 1,600$2,5280.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders